RAPT RAPT Therapeutics, Inc.
Healthcare$58.01+0.00%ClosedMarket Cap: $959.3M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$58.00
Target (Median)
$58.00
Target Range
$58.00 - $58.00
Upside from current price: -0.0%
Rating Distribution
0 Strong Buy0 Buy9 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-21 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-01-21 | Barclays | downgrade | Equal Weight | Overweight |
| 2026-01-20 | TD Cowen | downgrade | Hold | Buy |
| 2026-01-20 | Clear Street | downgrade | Hold | Buy |
| 2026-01-20 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-01-20 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-01-20 | LifeSci Capital | downgrade | Market Perform | Outperform |
| 2025-11-12 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-07 | Barclays | maintain | Overweight | Overweight |
| 2025-11-03 | Wells Fargo | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.17 | $10.2M | 4 |
| Fri Dec 31 | $-3.71 | $805.4K | 3 |
| Sun Dec 31 | $-4.80 | $83.7M | 3 |
| Mon Dec 31 | $-6.47 | $18.1M | 1 |